Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.

[1]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[2]  S. Dong,et al.  DC‐STAMP, the Key Fusion‐Mediating Molecule in Osteoclastogenesis , 2014, Journal of cellular physiology.

[3]  S. Gordon,et al.  In Vitro Generation of Mature Human Osteoclasts , 2011, Calcified Tissue International.

[4]  Xu Feng,et al.  Disorders of bone remodeling. , 2011, Annual review of pathology.

[5]  L. Melton,et al.  The Unitary Model for Estrogen Deficiency and the Pathogenesis of Osteoporosis: Is a Revision Needed? , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Gerdhem,et al.  Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Qingxia Zhao,et al.  Cathepsin K: a therapeutic target for bone diseases. , 2009, Biochemical and biophysical research communications.

[8]  M. Eijken,et al.  Evidence for multiple peroxisome proliferator‐activated receptor γ transcripts in bone: Fine‐tuning by hormonal regulation and mRNA stability , 2008, FEBS letters.

[9]  A. Hofman,et al.  The RIZ Pro704 insertion-deletion polymorphism, bone mineral density and fracture risk: the Rotterdam study. , 2008, Bone.

[10]  P. Bernabei,et al.  Risedronate Reduces Osteoclast Precursors and Cytokine Production in Postmenopausal Osteoporotic Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[12]  S. Cummings,et al.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.

[13]  A. Uitterlinden,et al.  The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Pescarmona,et al.  Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  R. Cumming,et al.  Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  M. Brown,et al.  Osteoclast formation from circulating precursors in osteoporosis , 2003, Scandinavian journal of rheumatology.

[17]  A. Hofman,et al.  The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  B. Dawson-Hughes,et al.  Secondary hyperparathyroidism and bone turnover in elderly blacks and whites. , 2001, The Journal of clinical endocrinology and metabolism.

[19]  J. de Dios Luna,et al.  Relation Between Vitamin D Insufficiency, Bone Density, and Bone Metabolism in Healthy Postmenopausal Women , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  P. Delmas,et al.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  A. Hofman,et al.  Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study , 1996, BMJ.

[22]  T. Martin,et al.  Structural and functional correlations in parathyroid hormone responsive transplantable osteogenic sarcomas. , 1979, European journal of cancer.

[23]  Ankita Agrawal,et al.  Human osteoclast culture and phenotypic characterization. , 2012, Methods in molecular biology.

[24]  L. Melton,et al.  Involutional osteoporosis. , 1986, The New England journal of medicine.